HOME >> BIOLOGY >> NEWS
Pitt Professor awarded competitive Sloan Research Fellowship

PITTSBURGH--Marc Sommer, assistant professor in the University of Pittsburgh's Department of Neuroscience, has received an Alfred P. Sloan Research Fellowship, a competitive award given to the "very best" scientists at an early stage in their faculty careers.

The two-year, $45,000 award will fund Sommer's research into how brain areas communicate with each other during normal behaviors, and how this communication breaks down in such mental disorders as schizophrenia. Sommer studies the signals sent from deep brain structures, such as the cerebellum, to the prefrontal cortex, considered to be the seat of cognitive abilities.

Sommer is investigating how this input to prefrontal cortex normally influences how we see, move, and make decisions, and how the flow of information is altered in an animal model of schizophrenia. To do this, he "eavesdrops" on single nerve cells using fine electrodes with microscopic tips, and also determines the inputs and outputs of the cells.

"Marc's approach, the creativity he brings to what he does, is quite unusual for a starting-out scientist," said Alan Sved, chair of Pitt's neuroscience department. "There's no question in my mind and those of the faculty in the department that Marc is the most outstanding young scientist now working in the area of sensorimotor processing in primate cortex."

The Alfred P. Sloan Foundation, a philanthropic nonprofit institution, was established in 1934 by Alfred Pritchard Sloan Jr., then-president and chief executive officer of the General Motors Corporation. The Sloan Research Fellowships were established in 1955 to provide support and recognition to early-career scientists and scholars, often in their first appointments to university faculties, who were endeavoring to set up laboratories and establish their independent research projects with little or no outside support. Currently, a total of 116 fellowships are awarded annually in seven fields: chemistry, computational
'"/>

Contact: Karen Hoffmann
klh52@pitt.edu
412-624-4356
University of Pittsburgh
5-May-2005


Page: 1 2

Related biology news :

1. UCSB Assistant Professor Patrick Daugherty wins Young Investigator Award from ACS
2. Krber Prize to ETH Zurich Professor Seeberger
3. Professors to develop hand-held pathogen testing device
4. Professor analyzes nuclear receptors in bee genome
5. Professor earns carbon sequestration research grant
6. Tufts David Walt named Howard Hughes Medical Institute Professor
7. Richard Zare named Howard Hughes Medical Institute Professor
8. Stevens Professor Alan Blumberg to speak at New York Public Library
9. Yale Public Health Professor elected fellow of the American Statistical Association
10. Allergies affect 15 million people in UK, says Professor
11. Jan Lwe awarded 2007 EMBO Gold Medal

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Pitt Professor awarded competitive Sloan Research Fellowship

(Date:1/22/2015)... Technology Showcase, Hall E -   EyeLock Inc. , a ... will showcase its EyeLock ID technology integrated in a 3D ... Oak Ridge National Laboratory (ORNL) at the 2015 ... authentication technology is being used to validate the driver and ...
(Date:1/22/2015)... , Jan. 16, 2015  A man-made form of ... and other mental capabilities in adults with mild cognitive ... study led by researchers at Wake Forest Baptist Medical ... diagnosed with amnesic mild cognitive impairment (MCI) or mild ...
(Date:1/22/2015)... YORK and POINT ROBERTS, Washington ... news source covering leading sectors including technology and tech stocks, ... Privacy marketplace featuring master pickpocket and security consultant Apollo ... is stolen and talks about the Wocket™ biometric smart wallet, ...
Breaking Biology News(10 mins):EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 3
(Date:2/27/2015)... , Feb. 27, 2015 A ... the NCATS rare-diseases portfolio " in Science ... new financing technique to reduce the risk associated ... and potentially unlock new levels of funding for ... product of a unique collaboration between scientists at ...
(Date:2/27/2015)... 27, 2015  Pfenex Inc. (NYSE MKT: PFNX), a ... therapeutics, today announced that it will be presenting at ... March 2 nd at 3pm PST. Patrick Lucy, chief ... discussing the current state of the biosimilar industry landscape ... For more information on CALBIO 2015 and ...
(Date:2/26/2015)... -- S&P Capital IQ (MHFI) announced today that it ... Therapeutics Holdings Inc . MabVax Therapeutics ... focused on the development of vaccine and antibody-based therapies ... cancer. MabVax has discovered a pipeline of human monoclonal ... by patients who have been immunized against targeted cancers. ...
(Date:2/26/2015)... 2015   Regulus Therapeutics Inc . (NASDAQ: ... and development of innovative medicines targeting microRNAs, today announced ... Chief Executive Officer of Regulus, will present a company ... Annual Healthcare Conference on Wednesday, March 4, 2015 at ... the Boston Marriott Copley Place.  The ...
Breaking Biology Technology:New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 2New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 3New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 2Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 3
Cached News: